Skip to content
Open access

Analysis of APC promoter 1B deletions in Russian families with familial adenomatous polyposis

Aug 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 26 references
Medicine

TL;DR

The APC 1B promoter deletions analyzed in this study had arisen independently and there is thus no evidence of a founder effect and WGS did not provide an added diagnostic benefit to MLPA aside from precisely determining the deletion breakpoints.

Abstract

Objective Familial adenomatous polyposis (FAP) is a severe autosomal dominant hereditary cancer syndrome. Patients develop hundreds of adenomatous polyps throughout the colon with the risk of colorectal cancer, if untreated, approaching 100%. FAP is caused by pathogenic germline variants in the APC gene. Deletions in the APC 1B promoter cause FAP in a small subgroup of patients. Previous studies suggested that the APC promoter deletions in unrelated FAP patients from the US and Italy are identical and may thus have spread from a single founder. The aim of this study was to investigate whether a similar founder effect can be detected in the Russian population. Patients and methods We performed whole-genome sequencing on five unrelated patients (three males and two females) with extensive (over 100) colon polyps, family history of FAP, and germline APC 1B promoter deletions previously detected by the multiplex ligation-dependent probe amplification (MLPA) and detected precise deletion boundaries. Results The patients carried deletions in the APC 1B promoter ranging from ~3 to ~122 kbp. We found no association between the deletion size and either the age of the onset or severity of the disease. All deletions were unique and no identical deletion boundaries were observed. However, in four patients, the right deletion breakpoints fell into a 1 kbp region downstream of the 1B promoter. The right breakpoints of several deletions detected in FAP patients from other countries also fell into this narrow region. Conclusion The APC 1B promoter deletions analyzed in this study had arisen independently and there is thus no evidence of a founder effect. Therefore, at least for the cohort of FAP patients with APC 1B promoter deletions studied here, WGS did not provide an added diagnostic benefit to MLPA aside from precisely determining the deletion breakpoints.

Read PDF

Similar papers

risk variants at

Z. Ghorbanoghli, M. Nieuwenhuis, J. Houwing-Duistermaat et al. · 7 citations
Open access Sep 2026

Colon cancer in a patient with a mosaic monoallelic germline pathogenic NF1 gene variant

This case highlights the co-occurrence of an NF1 variant and dMMR colorectal cancer and underscores the need for further studies to determine whether this represents a coincidental finding or a biologically meaningful association.

Feras Alsabagh, Karam M. Chaaban, M. Girardo et al. · 0 citations
Open access Jan 2026

Identification of Novel Pathogenic Variants in Familial Adenomatous Polyposis Through Whole Genome Sequencing

It is demonstrated that cryptic pathogenic APC variants beyond the detection limits of routine genetic testing can be resolved through WGS combined with transcript‐level validation, highlighting the importance of transcript‐aware variant interpretation and supports the integration of genome‐wide sequencing and RNA‐base...

Sung-Ryung Choi, Min Jung Kim, Ja-Lok Ku et al. · 0 citations
Open access Jan 2026

Clinical and Genetic Spectrum of Large AIP Deletions

Two novel large AIP deletions are reported here and three additional three families, including an Albanian kindred associated with metastatic Hürthle cell thyroid carcinoma, are reported, including an Albanian kindred associated with metastatic Hürthle cell thyroid carcinoma.

T. S. Kolnikaj, Maren Ruka, A. Xhumari et al. · 0 citations
Sep 2026

Abstract B036: Systematic Germline and Tumor Genomic Analysis for Gene Discovery in Familial Pancreatic Cancer

A systematic discovery pipeline focused on families with multiple affected individuals, leveraging familial segregation and matched tumor analysis to identify novel hereditary PDAC susceptibility genes, highlighting the complexity of hereditary PDAC and support continued genetic and functional evaluation of the priorit...

Jing-Xiong Xu, Y. Goldberg, Amy Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.